enstilum 50 micrograme/0,5 mg/g
colep laupheim gmbh & co. kg - germania - combinatii (calcipotriolum+betamethasonum) - spuma cut. - 50micrograme/0,5mg/g - antipsoriazice de uz local alte antipsoriazice de uz local
cycloserine 250 mg capsule
macleods pharmaceuticals ltd - cicloserinum - capsule - 250 mg
abacavir and lamivudine 600 mg/300 mg comprimate filmate
macleods pharmaceuticals ltd - abacavirum + lamivudinum - comprimate filmate - 600 mg/300 mg
innohep 10000 ui anti-xa/ml
laboratoires leo - franta - tinzaparinum - sol. inj. in seringi preumplute - 10000ui anti-xa/ml - antitrombotice grupul heparinei
innohep 20000 ui anti-xa/ml
laboratoires leo - franta - tinzaparinum - sol. inj. in seringi preumplute - 20000ui anti-xa/ml - antitrombotice grupul heparinei
travocort 10 mg + 1 mg/g cremă
leo pharma a/s - isoconazolum + diflucortolonum - cremă - 10 mg + 1 mg/g
advantan milk 1mg/g
leo pharma manufacturing italy s.r.l. - italia - alprazolamum aceponat - emulsie cut. - 1mg/g - corticosteroizi simpli corticosteroizi cu potenta mare (grup iii)
protopic
leo pharma a/s - tacrolimus - dermatita, atopică - alte preparate dermatologice - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. loc de patru sau de mai multe ori pe an), care au avut un răspuns inițial la un maxim de șase săptămâni de tratament de două ori pe zi tacrolimus unguent (leziuni eliminate, aproape șterse sau ușor afectate).
kyntheum
leo pharma a/s - brodalumab - psoriazis - imunosupresoare - kyntheum este indicat pentru tratamentul psoriazisului placă moderată până la severă la pacienții adulți care sunt candidați pentru terapie sistemică.
adtralza
leo pharma a/s - tralokinumab - dermatita, atopică - alte preparate dermatologice - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.